These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 16565606

  • 1. [Clinical features of liver abscess developed after radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma].
    Kim MH, Choi MS, Choi YS, Kim DY, Lee JM, Paik SW, Lee JH, Koh KC, Yoo BC, Choi D, Rhee JC.
    Korean J Hepatol; 2006 Mar; 12(1):55-64. PubMed ID: 16565606
    [Abstract] [Full Text] [Related]

  • 2. [Quality of life of primary hepatocellular carcinoma patients after radiofrequency ablation].
    Wang YB, Chen MH, Yan K, Yang W, Dai Y, Yin SS.
    Ai Zheng; 2005 Jul; 24(7):827-33. PubMed ID: 16004809
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of radiofrequency ablation and transarterial chemoembolization for the treatment of a single hepatocellular carcinoma smaller than 4 cm].
    Yang MJ, An SY, Moon EJ, Lee MS, Hwang JA, Cheong JY, Won JH, Kim JK, Wang HJ, Cho SW.
    Korean J Hepatol; 2009 Dec; 15(4):474-85. PubMed ID: 20037266
    [Abstract] [Full Text] [Related]

  • 4. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection.
    Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, Watanabe T, Mine T, Tokai RFA Study Group.
    Cancer; 2010 Aug 01; 116(15):3638-44. PubMed ID: 20564097
    [Abstract] [Full Text] [Related]

  • 5. Comparable survival in patients with unresectable hepatocellular carcinoma treated by radiofrequency ablation or transarterial chemoembolization.
    Chok KS, Ng KK, Poon RT, Lam CM, Yuen J, Tso WK, Fan ST.
    Arch Surg; 2006 Dec 01; 141(12):1231-6. PubMed ID: 17178966
    [Abstract] [Full Text] [Related]

  • 6. [Radiofrequency ablation with or without transcather arterial chemoembolization for management of hepatocellular carcinoma].
    Li ZR, Kang Z, Qian JS, Zhu KS, Jiang ZB, Huang MS, Guan SH, Shan H.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Nov 01; 27(11):1749-51. PubMed ID: 18024306
    [Abstract] [Full Text] [Related]

  • 7. Radiofrequency ablation and chemoembolization for hepatocellular carcinoma.
    Georgiades CS, Hong K, Geschwind JF.
    Cancer J; 2008 Nov 01; 14(2):117-22. PubMed ID: 18391617
    [Abstract] [Full Text] [Related]

  • 8. Transcatheter arterial chemoembolization with or without radiofrequency ablation in the management of patients with advanced hepatic malignancy.
    Bloomston M, Binitie O, Fraiji E, Murr M, Zervos E, Goldin S, Kudryk B, Zwiebel B, Black T, Fargher S, Rosemurgy AS.
    Am Surg; 2002 Sep 01; 68(9):827-31. PubMed ID: 12356160
    [Abstract] [Full Text] [Related]

  • 9. Liver function as assessed by breath tests in patients with hepatocellular carcinoma.
    Palmieri VO, Grattagliano I, Minerva F, Pollice S, Palasciano G, Portincasa P.
    J Surg Res; 2009 Dec 01; 157(2):199-207. PubMed ID: 19540521
    [Abstract] [Full Text] [Related]

  • 10. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone.
    Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN.
    Eur J Radiol; 2012 Mar 01; 81(3):e189-93. PubMed ID: 21353417
    [Abstract] [Full Text] [Related]

  • 11. Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC.
    Yang P, Liang M, Zhang Y, Shen B.
    Adv Ther; 2008 Aug 01; 25(8):787-94. PubMed ID: 18670743
    [Abstract] [Full Text] [Related]

  • 12. [Comparision of different interventional therapies for primary liver cancer].
    Liu YM, Qin H, Wang CB, Fang XH, Ma QY.
    Zhonghua Zhong Liu Za Zhi; 2007 Mar 01; 29(3):232-5. PubMed ID: 17649645
    [Abstract] [Full Text] [Related]

  • 13. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S, Hamada T, Iida T, Nakamura I, Fujii K, Usui M, Isaji S, Ito K, Tagawa S, Takeda K, Yokoi H, Noguchi T.
    J Gastroenterol Hepatol; 2008 Mar 01; 23(3):482-90. PubMed ID: 18086115
    [Abstract] [Full Text] [Related]

  • 14. Radiofrequency ablation combined with transarterial chemoembolization for unresectable primary liver cancer.
    Wang YH, Liu JF, Li F, Li A, Liu Q, Liu DB, Liu DG, Wang YJ.
    Chin Med J (Engl); 2009 Apr 20; 122(8):889-94. PubMed ID: 19493409
    [Abstract] [Full Text] [Related]

  • 15. Comparison of radiofrequency ablation and transarterial chemoembolization for hepatocellular carcinoma within the Milan criteria: a propensity score analysis.
    Hsu CY, Huang YH, Chiou YY, Su CW, Lin HC, Lee RC, Chiang JH, Huo TI, Lee FY, Lee SD.
    Liver Transpl; 2011 May 20; 17(5):556-66. PubMed ID: 21506244
    [Abstract] [Full Text] [Related]

  • 16. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL, Furth EE, Olthoff K, Shaked A, Soulen MC.
    J Gastrointestin Liver Dis; 2009 Jun 20; 18(2):169-76. PubMed ID: 19565046
    [Abstract] [Full Text] [Related]

  • 17. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W, Shi J, Xie WF.
    Liver Int; 2010 May 20; 30(5):741-9. PubMed ID: 20331507
    [Abstract] [Full Text] [Related]

  • 18. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial.
    Peng ZW, Zhang YJ, Chen MS, Xu L, Liang HH, Lin XJ, Guo RP, Zhang YQ, Lau WY.
    J Clin Oncol; 2013 Feb 01; 31(4):426-32. PubMed ID: 23269991
    [Abstract] [Full Text] [Related]

  • 19. The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization.
    Yau T, Yao TJ, Chan P, Epstein RJ, Ng KK, Chok SH, Cheung TT, Fan ST, Poon RT.
    Cancer; 2009 Dec 01; 115(23):5507-15. PubMed ID: 19701904
    [Abstract] [Full Text] [Related]

  • 20. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L, Shusang V, Buscombe JR, Cholongitas E, Stigliano R, Davies N, Tibballs J, Patch D, Meyer T, Burroughs AK.
    J Nucl Med; 2009 Jun 01; 50(6):871-7. PubMed ID: 19443599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.